Yasuhiro Hida

14PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 15, 2026
Biglycan Secreted by Tumor Stromal Cells Is a Predictive Marker for the Early Recurrence of Pancreatic Cancer.

|Dec 14, 2023
Oral bacterium Streptococcus mutans promotes tumor metastasis through thrombosis formation.

Li Yu, Yuying Hong, Nako Maishi

|May 30, 2023
High density and proximity of CD8+ T cells to tumor cells are correlated with better response to nivolumab treatment in metastatic pleural mesothelioma.

Yuting Yin, Rie Sakakibara, Takayuki Honda

|Oct 28, 2022
Stroma biglycan expression can be a prognostic factor in prostate cancers.

Jun Furumido, Nako Maishi, Aya Yanagawa-Matsuda

|Aug 23, 2022
The oral bacterium Streptococcus mutans promotes tumor metastasis by inducing vascular inflammation.

Li Yu, Nako Maishi, Erika Akahori

|Mar 10, 2022
Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell-specific liposomal siRNA delivery system.

Nako Maishi, Yu Sakurai, Hiroto Hatakeyama

Pageof 3

Frequent Collaborators

6 joint publications

Kyoko Hida

2 joint publications

Ryo Takeda

2 joint publications

Hiroshi Kikuchi

2 joint publications

Li Yu